PHARMA INSUMOS supplier risk profile Q1-2026: Mexico importer, 52 shipments, UK sourcing.
PHARMA INSUMOS (Mexico) recorded 52 shipments in Q1 2026 across 2 suppliers, all sourced from the United Kingdom (100% of shipment volume). The importer's trade is heavily concentrated in HS Chapter 38 (Miscellaneous chemical products), which accounts for approximately 94% of shipments. LGC STANDARDS PROFICIENCY TESTING is the dominant supplier, handling 49 of the 52 recorded shipments.
Trigram screen against OFAC SDN, BIS Entity List, UFLPA Entity List, SAM Exclusions, EU FSF, UK HMT, UN SC, and 25+ allied jurisdictions.
Distance-screened against all 380 facilities in the ASPI Xinjiang Data Project. Proximity score: 100 / 100.
PHARMA INSUMOS has zero sanctions watchlist matches and no identified supplier exposure to forced-labor risks under the UFLPA framework. The importer's compliance profile presents no flagged concerns in these two primary risk areas.
2 distinct tier-1 suppliers in Q1 2026
| LGC STANDARDS PROFICIENCY TESTING | United Kingdom | 49 |
| LGC STANDARDS PROFIENCY TESTING | United Kingdom | 3 |
Share of Q1 2026 inbound shipments by source country
2 tier-2 + 0 tier-3 nodes mapped - sign up to see them.
Free Tarifflo account unlocks the complete tier 1 / 2 / 3 supplier graph, daily refresh, alerts, and sanctions + UFLPA monitoring on every shipment.